[ASND] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
30-Sep-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- 9.31%
YoY- 38.85%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 57,833 48,034 15,290 1,113 2,757 2,243 20 276.99%
PBT -98,178 -161,578 -169,122 -80,343 -121,760 -25,174 -34,067 19.27%
Tax 1,020 645 -167 5 -19 -61 -100 -
NP -99,198 -162,223 -168,955 -80,348 -121,741 -25,113 -33,967 19.53%
Tax Rate - - - - - - - -
Total Cost 157,031 210,257 184,245 81,461 124,498 27,356 33,987 29.02%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -171.52 -337.73 -1,105.00 -7,219.05 -4,415.71 -1,119.62 -169,835.00 -68.29%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS 0.00 -2.88 -3.03 -1.47 -2.31 -0.53 -0.81 -
EPS Diluted 0.00 -2.88 -3.03 -1.47 -2.31 -0.53 -0.81 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.